Metropolis Healthcare Limited informed that Mr. Milind Sarwate (DIN: 00109854) has completed his term of 5 (five) years as an Independent Director of the Company on September 06, 2023. Consequently, he ceased to be a Director of the Company and Chairman/Member of Audit Committee, Risk Management Committee and Corporate Social Responsibility Committee with effect from the closure of business hours on September 06, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,054 INR | -0.23% |
|
+0.77% | +22.37% |
Jul. 09 | Metropolis Healthcare Clocks 13% Increase in Fiscal Q1 Overall Revenue | MT |
May. 22 | Metropolis Healthcare Limited to Seek Acquisitions | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.37% | 1.26B | |
-17.43% | 8.58B | |
+76.62% | 4.54B | |
+14.48% | 2.94B | |
-3.15% | 2.65B | |
-8.59% | 1.89B | |
-53.65% | 1.86B | |
-13.64% | 1.56B | |
-46.33% | 1.09B | |
+16.04% | 963M |
- Stock Market
- Equities
- METROPOLIS Stock
- News Metropolis Healthcare Limited
- Metropolis Healthcare Limited Announces the Cessation of Milind Sarwate as an Independent Director, Chairman/Member of Audit Committee, Risk Management Committee and Corporate Social Responsibility Committee, Effective September 06, 2023